$NTRA
Natera, Inc.

2021 Q4 Form 10-Q Financial Statement

#000155837021014721 Filed on November 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $173.0M $158.1M $112.4M
YoY Change 53.94% 61.11% 35.03%
Cost Of Revenue $94.12M $81.37M $59.90M
YoY Change 57.13% 57.09% 34.61%
Gross Profit $78.91M $76.75M $52.50M
YoY Change 50.3% 65.76% 35.39%
Gross Profit Margin 45.6% 48.54% 46.71%
Selling, General & Admin $146.8M $128.5M $94.10M
YoY Change 55.96% 69.78% 60.58%
% of Gross Profit 185.99% 167.42% 179.24%
Research & Development $71.81M $98.46M $32.40M
YoY Change 121.64% 272.65% 116.0%
% of Gross Profit 91.01% 128.29% 61.71%
Depreciation & Amortization $2.995M $2.997M $2.390M
YoY Change 25.31% 37.48% 32.04%
% of Gross Profit 3.8% 3.91% 4.55%
Operating Expenses $218.6M $226.9M $126.4M
YoY Change 72.92% 122.28% 71.74%
Operating Profit -$139.7M -$150.2M -$73.90M
YoY Change 88.99% 169.28% 112.22%
Interest Expense -$2.079M $2.078M -$4.300M
YoY Change -51.65% -51.33% 65.38%
% of Operating Profit
Other Income/Expense, Net $1.151M $1.274M $1.900M
YoY Change -39.42% -25.06% -13.64%
Pretax Income -$140.6M -$151.0M -$76.40M
YoY Change 84.02% 159.02% 117.05%
Income Tax -$30.00K $272.0K $0.00
% Of Pretax Income
Net Earnings -$140.6M -$151.3M -$76.40M
YoY Change 83.98% 159.37% 117.15%
Net Earnings / Revenue -81.24% -95.67% -67.97%
Basic Earnings Per Share -$1.63
Diluted Earnings Per Share -$1.482M -$1.634M -$890.4K
COMMON SHARES
Basic Shares Outstanding 94.59M 93.78M 85.37M
Diluted Shares Outstanding 92.56M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $914.3M $1.024B $737.3M
YoY Change 24.0% 26.45% 67.19%
Cash & Equivalents $84.39M $95.10M $48.67M
Short-Term Investments $829.9M $928.6M $688.6M
Other Short-Term Assets $29.87M $29.09M $26.80M
YoY Change 11.47% 88.87% 62.42%
Inventory $26.91M $28.02M $20.03M
Prepaid Expenses
Receivables $122.1M $110.4M $78.57M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.093B $1.191B $862.7M
YoY Change 26.72% 30.04% 64.89%
LONG-TERM ASSETS
Property, Plant & Equipment $65.52M $59.29M $33.35M
YoY Change 96.46% 109.89% 43.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $18.82M $13.20M $14.74M
YoY Change 27.65% 8.6% 18.17%
Total Long-Term Assets $143.3M $120.2M $69.49M
YoY Change 106.29% 97.94% 16.81%
TOTAL ASSETS
Total Short-Term Assets $1.093B $1.191B $862.7M
Total Long-Term Assets $143.3M $120.2M $69.49M
Total Assets $1.236B $1.311B $932.2M
YoY Change 32.65% 34.26% 59.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.21M $8.181M $8.096M
YoY Change 236.04% -11.56% -5.9%
Accrued Expenses $114.9M $96.49M $60.41M
YoY Change 90.13% 53.41% 23.17%
Deferred Revenue $7.404M $9.667M $50.13M
YoY Change -85.23% -81.13% -10.52%
Short-Term Debt $50.05M $50.00M $50.05M
YoY Change 0.0% -0.2% -0.14%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $219.0M $199.7M $199.1M
YoY Change 10.0% 1.96% 10.66%
LONG-TERM LIABILITIES
Long-Term Debt $280.4M $280.1M $202.5M
YoY Change 38.47% 40.04% 174.76%
Other Long-Term Liabilities $1.479M $1.464M $320.0K
YoY Change 362.19% 372.26% 3.23%
Total Long-Term Liabilities $1.479M $1.464M $320.0K
YoY Change 362.19% 372.26% 3.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $219.0M $199.7M $199.1M
Total Long-Term Liabilities $1.479M $1.464M $320.0K
Total Liabilities $583.2M $552.4M $445.9M
YoY Change 30.78% 25.33% 46.71%
SHAREHOLDERS EQUITY
Retained Earnings -$1.395B -$1.300B -$929.3M
YoY Change 50.09% 52.42% 32.92%
Common Stock $2.050B $2.012B $1.411B
YoY Change 45.29% 45.39% 44.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $653.3M $759.0M $486.2M
YoY Change
Total Liabilities & Shareholders Equity $1.236B $1.311B $932.2M
YoY Change 32.65% 34.26% 59.98%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income -$140.6M -$151.3M -$76.40M
YoY Change 83.98% 159.37% 117.15%
Depreciation, Depletion And Amortization $2.995M $2.997M $2.390M
YoY Change 25.31% 37.48% 32.04%
Cash From Operating Activities -$98.74M -$91.06M -$73.30M
YoY Change 34.7% 174.86% 387.04%
INVESTING ACTIVITIES
Capital Expenditures -$13.29M -$17.41M -$7.530M
YoY Change 76.49% 797.27% 211.16%
Acquisitions
YoY Change
Other Investing Activities $92.79M -$414.0M -$91.64M
YoY Change -201.26% 281.92% -52.48%
Cash From Investing Activities $79.50M -$431.4M -$99.16M
YoY Change -180.18% 290.94% -49.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $551.2M
YoY Change 103.39%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.515M 554.8M 11.80M
YoY Change -27.84% 101.28% -94.65%
NET CHANGE
Cash From Operating Activities -98.74M -91.06M -73.30M
Cash From Investing Activities 79.50M -431.4M -99.16M
Cash From Financing Activities 8.515M 554.8M 11.80M
Net Change In Cash -10.72M 32.29M -160.7M
YoY Change -93.33% -75.56% -1656.78%
FREE CASH FLOW
Cash From Operating Activities -$98.74M -$91.06M -$73.30M
Capital Expenditures -$13.29M -$17.41M -$7.530M
Free Cash Flow -$85.45M -$73.65M -$65.77M
YoY Change 29.92% 136.15% 420.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000
us-gaap Net Income Loss
NetIncomeLoss
-153331000
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-950000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
94538000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86223000
dei Entity Registrant Name
EntityRegistrantName
Natera, Inc.
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Central Index Key
EntityCentralIndexKey
0001604821
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Shell Company
EntityShellCompany
false
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y7M28D
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Entity File Number
EntityFileNumber
001-37478
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
01-0894487
dei Entity Address Address Line1
EntityAddressAddressLine1
13011 McCallen Pass
dei Entity Address Address Line2
EntityAddressAddressLine2
Building A Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78753
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
249-9090
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
NTRA
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
94594816
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95103000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48668000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
228000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
187000
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
928596000
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
688606000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2965000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3080000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
110416000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
78565000
CY2021Q3 us-gaap Inventory Net
InventoryNet
28022000
CY2020Q4 us-gaap Inventory Net
InventoryNet
20031000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
28858000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26606000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
1191223000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
862663000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59293000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33348000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
47656000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21399000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13202000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14743000
CY2021Q3 us-gaap Assets
Assets
1311374000
CY2020Q4 us-gaap Assets
Assets
932153000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8181000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8096000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
35331000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30371000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
96486000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60407000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9667000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
50125000
CY2021Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
50049000
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
50054000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
199714000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
199053000
CY2021Q3 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
280085000
CY2020Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
202493000
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
22706000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
22805000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48388000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21246000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1464000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
320000
CY2021Q3 us-gaap Liabilities
Liabilities
552357000
CY2020Q4 us-gaap Liabilities
Liabilities
445917000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
94538000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86223000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
10000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2011788000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1411286000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1254272000
us-gaap Operating Income Loss
OperatingIncomeLoss
-142309000
CY2021Q3 us-gaap Interest Expense
InterestExpense
2078000
CY2020Q3 us-gaap Interest Expense
InterestExpense
4270000
us-gaap Interest Expense
InterestExpense
6226000
us-gaap Interest Expense
InterestExpense
10772000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1274000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-151273000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-58323000
us-gaap Net Income Loss
NetIncomeLoss
-331152000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-929318000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1491000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4259000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
759017000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
486236000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1311374000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
932153000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
158116000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
98143000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
452458000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
278627000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
98457000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26421000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
192397000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
67651000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
128485000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
75678000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
364273000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
209547000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
308313000
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
153920000
us-gaap Costs And Expenses
CostsAndExpenses
780966000
us-gaap Costs And Expenses
CostsAndExpenses
420936000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-150197000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-55777000
us-gaap Operating Income Loss
OperatingIncomeLoss
-328508000
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1749000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4230000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5661000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5848000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-151001000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58298000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-330504000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-153268000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
272000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
648000
us-gaap Net Income Loss
NetIncomeLoss
-331152000
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
82873000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
270650000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34406000
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-600000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-2768000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4251000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-152223000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58923000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-333920000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-149080000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.63
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.72
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.72
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.93
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
92558000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
80908000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
89130000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79430000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
304267000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4974000
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
270650000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15032000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-600000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-58323000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
536000000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
278711000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15782000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3062000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
4251000
ntra Cumulative Effect Of New Accounting Principle In Period Of Adoption Duration
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionDuration
-404000
us-gaap Net Income Loss
NetIncomeLoss
-153331000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
536000000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
299110000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3945000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
550822000
CY2021Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
30901000
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
3000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26459000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-950000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-151273000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
759017000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
486236000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10774000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6085000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
550822000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
30901000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
84797000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-2768000
ntra Cumulative Effect Of New Accounting Principle In Period Of Adoption Duration
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionDuration
-76678000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
759017000
us-gaap Profit Loss
ProfitLoss
-331152000
us-gaap Profit Loss
ProfitLoss
-153331000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8259000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6215000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
35604000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
5707000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
3333000
us-gaap Gain Loss On Investments
GainLossOnInvestments
58000
us-gaap Share Based Compensation
ShareBasedCompensation
84797000
us-gaap Share Based Compensation
ShareBasedCompensation
34406000
us-gaap Operating Lease Cost
OperatingLeaseCost
8106000
us-gaap Operating Lease Cost
OperatingLeaseCost
5819000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
917000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
149000
ntra Inventory Reserve Adjustments
InventoryReserveAdjustments
726000
ntra Inventory Reserve Adjustments
InventoryReserveAdjustments
-180000
ntra Other Non Cash Benefits Charges
OtherNonCashBenefitsCharges
133000
ntra Other Non Cash Benefits Charges
OtherNonCashBenefitsCharges
-135000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
380000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1445000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5848000
ntra Accretion Of Convertible Notes Interest Expense Debt
AccretionOfConvertibleNotesInterestExpenseDebt
4514000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
32232000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17940000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8717000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7803000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7851000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7288000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
550000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-97000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
183000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1613000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4960000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
6362000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
34845000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
16362000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-40557000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5470000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-236500000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-109210000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
674372000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
479037000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
77563000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
11500000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
348410000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
247315000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32027000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12073000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4271000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-284697000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-232295000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10774000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
78757000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
6085000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
550814000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
270650000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15782000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
3062000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
278316000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
567673000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
489053000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
46476000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
147548000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48855000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61981000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95331000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
209529000
us-gaap Interest Paid Net
InterestPaidNet
3690000
us-gaap Interest Paid Net
InterestPaidNet
3137000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4957000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2814000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q3 ntra Number Of Subsidiaries
NumberOfSubsidiaries
2
us-gaap Net Income Loss
NetIncomeLoss
-331200000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1300000000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95300000
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
928600000
CY2021Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
50000000.0
CY2021Q2 us-gaap Other Commitment
OtherCommitment
10000000
CY2021Q2 ntra Payments For Third Party Assets If Purchase Option Exercised
PaymentsForThirdPartyAssetsIfPurchaseOptionExercised
290000000.0
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
77600000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11500000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:40.3pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in accordance with generally accepted accounting principles (GAAP) in the United States requires management to make estimates and assumptions about future events that affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Significant items subject to such estimates include the allowance for doubtful accounts calculated based on the average selling price expected to be received from insurance payors, the operating right-of-use assets and the associated lease liabilities, deferred revenues associated with unsatisfied performance obligations, accrued liability for potential refund requests, the valuation of the Convertible Notes, stock-based compensation, the fair value of options, income tax uncertainties, and the expected consideration to be received from contracts with customers. These estimates and assumptions are based on management's best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors, including contractual terms and statutory limits; however, actual results could differ from these estimates and could have an adverse effect on the Company's financial statements.</p>
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4220000
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
380000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
495000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4105000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:10pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Risk and Uncertainties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company is subject to risks and uncertainties as a result of the COVID-19 pandemic. The extent of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict, and the full extent and duration of the impact of the COVID-19 pandemic on its business, its operations, and the global economy as a whole is not yet known. While the Company’s test volumes and overall average selling prices for its tests increased during the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020, the Company cannot predict the potential nature, magnitude and duration of the effects of the COVID-19 pandemic on the macroeconomic environment or its business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to credit risk consist of cash, accounts receivable and investments. The Company limits its exposure to credit loss by placing its cash in financial institutions with high credit ratings. The Company's cash may consist of deposits held with banks that may at times exceed federally insured limits. The Company performs evaluations of the relative credit standing of these financial institutions and limits the amount of credit exposure with any one institution. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company performs evaluations of financial conditions for insurance carriers, patients, clinics and laboratory partners and generally does not require collateral to support credit sales. For the nine months ended September 30, 2021, and 2020, there were no customers exceeding 10% of total revenues on an individual basis. As of September 30, 2021 and December 31, 2020, there were no customers with an outstanding balance exceeding 10% of net accounts receivable. </p>
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1491000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5170000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4259000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
919000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1491000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5170000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
278627000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2441000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5770000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
158116000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
98143000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
452458000
CY2021Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
43
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
50125000
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
22706000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
22805000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
32373000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
158116000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
98143000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
452458000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
278627000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
110416000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
78565000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9667000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
72930000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
72930000
ntra Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
4703000
ntra Contract With Customer Liability Refunds Of Revenues Previously Deferred
ContractWithCustomerLiabilityRefundsOfRevenuesPreviouslyDeferred
10000000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-32864000
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
-2396000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
32373000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-32900000
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
403211000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
403784000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
523885000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
524812000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
927096000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
928596000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
117607000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
83402000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58314000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
50054000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59293000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33348000
us-gaap Depreciation
Depreciation
8300000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2472000
CY2020Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2260000
CY2021Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
10950000
CY2020Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
12686000
CY2021Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
12275000
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
9635000
CY2021Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
9634000
CY2020Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
5790000
CY2020Q4 ntra Accrued Shipping Charges
AccruedShippingCharges
1604000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
35331000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30371000
CY2021Q3 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
15879000
CY2020Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
17366000
CY2021Q3 ntra Accrued Charges For Outsourced Testing
AccruedChargesForOutsourcedTesting
17690000
CY2020Q4 ntra Accrued Charges For Outsourced Testing
AccruedChargesForOutsourcedTesting
5141000
CY2021Q3 ntra Accrued Testing And Laboratory Materials From Suppliers
AccruedTestingAndLaboratoryMaterialsFromSuppliers
6513000
CY2020Q4 ntra Accrued Testing And Laboratory Materials From Suppliers
AccruedTestingAndLaboratoryMaterialsFromSuppliers
2720000
CY2021Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
6152000
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3325000
CY2021Q3 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
15215000
CY2020Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
4189000
CY2021Q3 ntra Accrued Shipping Charges
AccruedShippingCharges
399000
CY2021Q3 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1758000
CY2020Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1723000
CY2021Q3 ntra Accrued Specimen Service Fees
AccruedSpecimenServiceFees
3363000
CY2020Q4 ntra Accrued Specimen Service Fees
AccruedSpecimenServiceFees
2355000
CY2021Q3 ntra Accrued Clinical Trials And Studies
AccruedClinicalTrialsAndStudies
6282000
CY2020Q4 ntra Accrued Clinical Trials And Studies
AccruedClinicalTrialsAndStudies
2353000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6922000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7300000
CY2021Q3 ntra Accrued Fixed Asset Purchases
AccruedFixedAssetPurchases
4957000
CY2020Q4 ntra Accrued Fixed Asset Purchases
AccruedFixedAssetPurchases
1691000
CY2021Q3 ntra Accrued Interest
AccruedInterest
2695000
CY2020Q4 ntra Accrued Interest
AccruedInterest
1078000
CY2021Q3 ntra Other Accrued Sundry Expenses Current
OtherAccruedSundryExpensesCurrent
8661000
CY2020Q4 ntra Other Accrued Sundry Expenses Current
OtherAccruedSundryExpensesCurrent
9562000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
96486000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60407000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
69289000
us-gaap Operating Lease Payments
OperatingLeasePayments
6600000
CY2020Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
17366000
CY2019Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
9410000
ntra Insurance Carrier Reserves Additions
InsuranceCarrierReservesAdditions
11776000
ntra Insurance Carrier Reserves Additions
InsuranceCarrierReservesAdditions
11912000
ntra Insurance Refunds To Carriers
InsuranceRefundsToCarriers
8664000
ntra Insurance Refunds To Carriers
InsuranceRefundsToCarriers
5244000
ntra Insurance Carrier Reserves Released
InsuranceCarrierReservesReleased
4599000
ntra Insurance Carrier Reserves Released
InsuranceCarrierReservesReleased
2756000
CY2021Q3 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
15879000
CY2020Q3 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
13322000
ntra Noncash Investing Activities Related To Right Of Use Assets
NoncashInvestingActivitiesRelatedToRightOfUseAssets
31300000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6922000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48388000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
55310000
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0748
CY2021Q3 us-gaap Lease Cost
LeaseCost
2800000
CY2020Q3 us-gaap Lease Cost
LeaseCost
1900000
us-gaap Lease Cost
LeaseCost
8100000
us-gaap Lease Cost
LeaseCost
5800000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
2600000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
2200000
us-gaap Operating Lease Payments
OperatingLeasePayments
7600000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2689000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10909000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
11456000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
11993000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12216000
CY2021Q3 ntra Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
20026000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13979000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
55310000
CY2021Q3 us-gaap Purchase Obligation
PurchaseObligation
90630000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
272000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
648000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000
us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2020Q3 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13600000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11500000
CY2021Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
5800000
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
12100000
CY2021Q3 ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-151273000
CY2020Q3 ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-58323000
ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-331152000
ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-153331000
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
92558000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
80908000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
89130000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79430000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.63
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.72
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.72
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.93
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17548000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18699000

Files In Submission

Name View Source Status
0001558370-21-014721-index-headers.html Edgar Link pending
0001558370-21-014721-index.html Edgar Link pending
0001558370-21-014721.txt Edgar Link pending
0001558370-21-014721-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ntra-20210930.xsd Edgar Link pending
ntra-20210930x10q.htm Edgar Link pending
ntra-20210930x10q_htm.xml Edgar Link completed
ntra-20210930xex10d1.htm Edgar Link pending
ntra-20210930xex31d1.htm Edgar Link pending
ntra-20210930xex31d2.htm Edgar Link pending
ntra-20210930xex32d1.htm Edgar Link pending
ntra-20210930xex32d2.htm Edgar Link pending
ntra-20210930xex3d1.htm Edgar Link pending
ntra-20210930xex3d1001.jpg Edgar Link pending
ntra-20210930_cal.xml Edgar Link unprocessable
ntra-20210930_def.xml Edgar Link unprocessable
ntra-20210930_lab.xml Edgar Link unprocessable
ntra-20210930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending